REPEAL REYES SYN REPORTING ACT
Illinois bill repealing synthetic drug reporting requirements, potentially limiting law enforcement monitoring of emerging drug trends and public health responses.
Illinois bill repealing synthetic drug reporting requirements, potentially limiting law enforcement monitoring of emerging drug trends and public health responses.
HB 4907 seeks to repeal the Reyes Synthetic Drug Reporting Act in Illinois. The bill would eliminate state-mandated reporting requirements for synthetic drug sales and related transactions that were established under the previous legislation.
The Reyes Act created regulatory oversight mechanisms for synthetic drugs (often called "designer drugs" or "legal highs"). Repealing it would remove these reporting requirements, potentially affecting law enforcement's ability to track emerging synthetic drug trends and respond to public health threats related to these substances.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.